Replies to post #320646 on Amarin Corp Plc (AMRN)

[sts66]

Share price is meaningless when comparing the value of companies - IFRX has a market cap of only $161M.

[HinduKush]

jasbg,
Can someone explain to me ?

TRIUMPH OF DOUBT OVER EXPERIENCE

1. Company A:

On the market for +8 years with 'groundbreaking Drug' - on the verge of Approval for Europe - China - a line of promising trials on Covid - Cancer - Nash. Company 'No Debt:

SP - as of today - $ 6,55
----------------------------

TRIUMPH OF HOPE DESPITE EXPERIENCE

2. Company B:

No product on the market - only Phase 2 trials - for a rather seldom decease - relative extensive debt:

SP - as of today - $ 6,71

HK

[mimurray]

The company you mentioned (IFRX) and Amarin are not very comparable. IFRX market cap is only about 160 million. Daily volume is only around 280 million shares per day. Their PPS has been right around 6.50 for the last year. They did also make a presentation at the JP Morgan Conference that was recently held.

The only way to compare them is to say that either IFRX is extremely over valued, or AMRN is extremely under valued at their current share prices.

I suspect both statements are probably accurate.